Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Lactose (India)BOM:524202 +2.06%77 Days Inventory is 151.04 as of Mar. 2026, which is 17% below its 10-year median of 182.81. GuruFocus rates BOM:524202 with a GF Score™ of 77/100 and a GF Value™ of ₹163.62 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 923 Drug Manufacturers companies, Lactose (India) ranks better than 78.87% on this metric.
The historical rank and industry rank for Lactose (India)'s Days Inventory or its related term are showing as below:
BOM:524202'
s Days Inventory Range Over the Past 10 Years
Min: 95.54 Med: 182.81 Max: 259.78
Current: 101.27
During the past 13 years, Lactose (India)'s highest Days Inventory was 259.78. The lowest was 95.54. And the median was 182.81.
BOM:524202's Days Inventory is ranked better than 78.87% of 923
companies
in the Drug Manufacturers industry
Industry Median: 164.87
vs BOM:524202: 101.27
Lactose (India)'s Days Inventory
increased
from Mar. 2025 (122.36) to Mar. 2026 (151.04).
It might indicate that Lactose (India)'s sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Lactose (India)'s Inventory Turnover for the
three
months ended in Mar. 2026 was 0.60.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Lactose (India)'s Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.22.
Lactose (India) (BOM:524202) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Lactose (India)'s Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Lactose (India)'s Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Lactose (India) Days Inventory Related Terms
Lactose (India) Days Inventory Historical Data
* Premium members only.
The historical data trend for Lactose (India)'s Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Lactose (India)'s Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lactose (India) Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Lactose (India)'s Days Inventory distribution charts can be found below:
* The bar in red indicates where Lactose (India)'s Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lactose (India) (BOM:524202) has a Days Inventory of 151.04 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Lactose (India) and its competitors. This is 17% below median its historical median of 182.81. Over the past decade, Lactose (India)'s Days Inventory has ranged from 95.54 to 259.78. According to the industry distribution chart, Lactose (India) ranks #195 out of 923 companies in the Drug Manufacturers industry, placing it in the top 21.1%.
Is Lactose (India)'s Days Inventory too high?
Lactose (India)'s current Days Inventory of 151.04 is 17% below median its 10-year median of 182.81. Over the past 10 years, this metric has ranged from a low of 95.54 to a high of 259.78. The Drug Manufacturers industry median Days Inventory is 164.87. Lactose (India)'s value of 151.04 is 8.4% below this industry median. Based on the distribution chart, Lactose (India) ranks #195 out of 923 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Lactose (India) has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lactose (India)'s Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Lactose (India) ranks #195 out of 923 companies for Days Inventory. This places Lactose (India) in the top 21% of its industry — outperforming the majority of peers. The industry median Days Inventory is 164.87. Lactose (India)'s value of 151.04 is 8.4% below this benchmark. Historically, Lactose (India)'s own Days Inventory has ranged from 95.54 to 259.78 over the past decade. While the company's 10-year median is 182.81 vs. the industry median of 164.87, Lactose (India) has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.87, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lactose (India)'s current Days Inventory of 151.04 is 8.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Lactose (India) and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lactose (India)'s current Days Inventory is 151.04, which is 17% below median its own 10-year median of 182.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lactose (India) stock overvalued right now?
Based on GuruFocus' analysis, Lactose (India) (BOM:524202) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹163.62, compared to a current price of ₹103.95 — trading 36.5% below its estimated fair value. The current Days Inventory is 151.04, which is 17% below median its 10-year median of 182.81 and 8.4% below the Drug Manufacturers industry median of 164.87. Lactose (India)'s overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Lactose (India) (BOM:524202), the current Days Inventory is 151.04 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lactose (India) (BOM:524202) Overvalued in 2026?
Based on GuruFocus' analysis, Lactose (India) stock appears to be undervalued.
The current stock price of ₹103.95 is trading 36.5% below its estimated GF Value™ of ₹163.62.
GuruFocus considers Lactose (India) to be Significantly Undervalued.
Key valuation signals for BOM:524202:
Days Inventory: 151.04 (17% below median its 10-year median of 182.81)
GF Value™: ₹163.62 vs. price of ₹103.95 (36.5% below fair value)
Industry Position: 8.4% below the Drug Manufacturers median (#195 of 923)
No single metric tells the full story. See the BOM:524202 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lactose (India) Ltd is an India based pharmaceutical company. It is principally engaged in the manufacturing and trading of pharmaceutical products. The company offers pharmaceutical products like Lactose monohydrate, Dry granulated, Film and lacquer coated tablets, Disaccharide lactulose, and Liquid dose form products. Manufacturing of lactose monohydrate and other pharmaceutical products generates revenue for the company. The company sells its products in India and also exports its products internationally.
77GF Score
Get the complete analysis for BOM:524202
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524202 has been successfully added to your 
